Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesInfluence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn's disease
Alimentary Pharmacology and Therapeutics, 08/20/09
Wehkamp MD et al. – Current oral drug treatment seems to have no major effect on the expression of antimicrobial peptides. In contrast to HBD2 and LL37, ileal levels of HD5 and HD6 and colonic HBD1 level are independent of current inflammation. Innovative drugs should aim to strengthen protective innate immunity.
Related Articles
A Case-Control Study on Risk Factors of Osteoporosis in Patients with Crohn's Disease
Archives of Iranian Medicine, 11/13/09
Relevance Score: 69%
Impact of disease activity on resting energy expenditure in children with inflammatory bowel disease
Clinical Nutrition, 11/18/09
Relevance Score: 68%
Gastrointestinal stromal tumor causing small bowel intussusception in a patient with Crohn's disease
World Journal of Gastroenterology, 11/13/09
Relevance Score: 68%
Pathogenesis of inflammatory bowel disease (IBD)
The Internet Journal of Gastroenterology, 11/13/09
Relevance Score: 68%
Methotrexate for maintenance of remission in Crohn's disease
Cochrane Reviews, 10/27/09
Relevance Score: 68%
Today in Inflammatory Bowel Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Elevated IL-13R[alpha]2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway
Inflammatory Bowel Disease, 12/15/09
Genome wide association (GWA) predictors of anti-TNF[alpha] therapeutic responsiveness in pediatric inflammatory bowel disease
Inflammatory Bowel Disease, 12/15/09
Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease
Inflammatory Bowel Disease, 12/15/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09
Medication Usage and the Risk of Neoplasia in Patients With Barretts Esophagus
Clinical Gastroenterology and Hepatology , 12/15/09
Investigational drugs for hepatitis C
Expert Opinion on Investigational Drugs, 12/15/09
Today in Small/Large Intestine...keeping you current
Receive free subspecialty "5-minute updates" via email
CD24 is upregulated in inflammatory bowel disease and stimulates cell motility and colony formation
Inflammatory Bowel Disease, 12/15/09
The relevance of transition zones on computed tomography in the management of small bowel obstruction
Surgery, 12/15/09
Image-guided conservative management of right colonic diverticulitis
World Journal of Gastroenterology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor